Participants
epileptic seizures, psychiatric, SD
NEUROLOGICAL DISORDER, RECRUITMENT, EPILEPTIC SEIZURE, HEART ATTACK
This study was carried out in accordance with the Declaration of Helsinki, reviewed and approved by the Stanford University Institutional Review Board, was performed in accordance with all relevant guidelines and regulations, and written informed consent was obtained from all participants. 52 healthy participants (19–65 years old [M = 44.4, SD = 13.3, 31F/20 M/1O]) responded to an online recruitment ad and after an initial online screening and consent, 18 eligible participants (25–60 years old [M = 42.9, SD = 11.8, 9F/9 M]) were enrolled. Two participants withdrew because rTMS was intolerable and the remaining 16 participants were included in the analyses (M = 43.1 years, SD = 12.5, 8F/8 M). See Table S1 for additional demographics.Inclusion criteria on the online screening form were (a) aged 18–65, (b) able to travel to study site, (c) fluent in English and (d) fully vaccinated against COVID-19. Exclusion criteria were (a) lifetime history of psychiatric or neurological disorder, (b) substance or alcohol abuse/dependence in the past month, (c) heart attack in the past 3 months, (d) pregnancy, (e) presence of any contraindications for rTMS, such as history of epileptic seizures or certain metal implants